Misdiagnosing the diseases of the poor
India's compliance with TRIPS will not hinder the poor's access to essential medicines; rather, it is the government's hold on the healthcare sector that makes equitable healthcare impossible. My article titled Misdiagnosing the diseases of the poor was published in The Indian Express on January 28 2005. The present debate over the Indian patent law, despite the passion, is underscored by the desire to score political points. Consequently, most of the arguments have been disconnected from reality. India has been a proving ground for those who oppose patents on pharmaceutical products. We scrapped all product patents in 1972. As a result, India is now home to over 20,000 pharmaceutical companies producing copies of drugs developed óand patentedó elsewhere. However, access to medicines remains pooró suggesting that patents are not the key determinant of access that their opponents claim. In India, medicine represents between 10 and 15% of total health care costs. This will...